trial

Comparison of a Speech-Language Assessment Tool for Pragmatic and Discourse Skills in Schizophrenia Spectrum Disorders

NCTId NCT05742893
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 30 (actual)
Sponsored by Centre Hospitalier Universitaire de Nice
Primary completion 2023-03-06
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
30 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2023-03-06
Primary completion
2023-03-06
Eligibility
ALL · 18 Years · 99 Years

Interventions & indications

Drugs
Measurement of pragmatic and discourse test scores in the two scales.

Sponsors

Centre Hospitalier Universitaire de NiceLead Sponsor

Investigators

1
Benoit MichelPrincipal Investigator

Sites

1 total
Nice, France

Facts & assertions

4 sourced
Enrollment
30
Phase
NA
Primary Completion Date
2023-03-06
Status
COMPLETED
relationships
The graph out of here
drug
Measurement of pragmatic and discourse test scores in the two scales.
drug
lead_sponsor
Centre Hospitalier Universitaire de Nice
company
indication
Psychotic Disorders
indication
Psychotic Disorders
indication
investigator
Benoit Michel
person